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Blinded Manuscript 
Volumetric upper airway changes after rapid maxillary expansion: a systematic review and meta-analysis  
 
Summary 
Objective: To investigate the volumetric changes in the upper airway spaces following Rapid Maxillary 
Expansion (RME) in growing subjects by means of acoustic rhinometry, three-dimensional radiography and 
digital photogrammetry.  
Search methods: Literature search of electronic databases and additional manual searches up to February 2016. 
Selection criteria: Randomized clinical trials, prospective or retrospective controlled clinical trials and cohort 
clinical studies of at least eight patients, where the RME appliance was left in place for retention, and a maximum 
follow-up of 8 months post-expansion. 
Data collection and analysis: After duplicate data extraction and assessment of the risk of bias, the mean 
differences (MDs) and 95% confidence intervals (CIs) of upper airway volume changes were calculated with 
random-effects meta-analyses, followed by subgroup analyses, meta-regressions, and sensitivity analyses. 
Results: Twenty studies were eligible for qualitative synthesis, of which 17 (3 controlled clinical studies and 14 
cohort studies) were used in quantitative analysis. As far as total airway volume is concerned patients treated with 
RME showed a significant increase both post-expansion (5 studies; increase from baseline: 1218.3 mm3; 95% CI: 
702.0 to 1734.6 mm3), which did not seem to considerably diminish after the retention period (11 studies; increase 
from baseline: 1143.9 mm3; 95% CI: 696.9 to 1590.9 mm3). However, the overall quality of evidence was judged 
as very low, due to methodological limitations of the included studies, absence of untreated control groups, and 
inconsistency among studies.  
Conclusions: RME seems to be associated with an increase in the nasal cavity volume in the short- and in the 
long-term. However, additional well-conducted prospective controlled clinical studies are needed to confirm the 
present findings. 
Registration: None. 
Funding: Australian Society of Orthodontics Foundation for Research and Education Inc. 
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Introduction 
Rationale 
Maxillary expansion as an orthodontic treatment modality has been reported since the 1860’s (1). Rapid Maxillary 
Expansion (RME) aims to resolve maxillary transverse deficiencies, correct posterior dental crossbites, create 
arch space for relief of crowding, prevent maxillary canine impaction, and reduce nocturnal enuresis (2-4). 
Separation of the maxillary halves extends directly to the nasal cavity through lateral separation of the nasal walls 
and lowering of the palatal vault (5). Reported benefits to the upper airway include improving allergic rhinitis, 
asthma, and recurrent ear or nasal infections (6). Many researchers have suggested that RME is a successful means 
of increasing the nasal permeability and reducing airway resistance, based on both objective and subjective 
evidence (7, 8). Reduced airway resistance reduces negative pressure during ventilation, with promising results 
of RME shown in the treatment of paediatric sleep disordered breathing, including obstructive sleep apnoea (9). 
The effects on more distant structures include stretching of the tensor palatine muscles by the expanding maxilla 
with subsequent improvement in drainage of the Eustachian tubes, aiding in reducing otitis media and conductive 
hearing loss (10). Enlarged palatal space may also allow for an improved tongue posture, which could facilitate 
increased airway space in the oropharynx (11). 
Decreased airflow can be observed in various parts of the upper airways. In cases of considerable 
obstruction to the nasal airflow, the respiratory pattern can shift towards mouth breathing, although breathing 
mode cannot be robustly predicted by nasal resistance data alone (8). On the other side some researchers suggest 
that reduced nasal volumes are associated with mouth breathing (12). The interrelationship between respiratory 
obstruction, malocclusion, and facial growth continues to be debated after nearly a century of controversy (13). 
Interest in this subject has been rekindled in the past decades, based on the possible role of craniofacial 
morphology, and especially the shape/ dimension of the upper airways, on obstructive sleep apnoea (14). 
Many studies have assessed linear transverse dental and skeletal changes produced by maxillary 
expansion, but these changes do not necessarily reflect airway dimension changes (15, 16). Previous reports 
indicate that maxillary expansion is associated with an increase in nasal width, cross-sectional area, and volume 
(5, 17, 18). Subjective improvement in nasal breathing has also been considered as a concomitant result (7, 8). 
However, evidence on the changes induced by RME on upper airway volumes further from the nasal cavity, 
particularly the pharynx, is still inconclusive. 
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Accurate quantification of RME-induced changes at the upper airways has been a challenge. Linear 
measurements as performed on cephalograms cannot accurately express the upper airways (19). On the other side, 
the dimensional accuracy of both conventional computed tomography (CT) and cone-beam computed tomography 
(CBCT) in quantifying the volume of the upper airway has long been verified (14, 20) with small method error, 
even though imaging reproducibility of dynamic regions has been suggested to be inconsistent (21). Although 
CBCT can offer reduced cost and radiation exposure to the patient compared to traditional CT, the latter shows 
reduced image noise, improved contrast resolution and accuracy to distinguish between soft tissues and air spaces 
over the former (22).  
Acoustic Rhinometry (AR), developed by Hilberg (23) can be used to objectively evaluate the nasal 
anatomy based on the reflection of sound waves within the nasal cavity. Measurements are then processed to 
calculate nasal cavity area, volume, and resistance (15). Use of a decongestant is common to produce readings 
that are minimally influenced by the highly dynamic nasal mucosal tissues (24). Although AR has been shown to 
have good agreement with magnetic resonance imaging and CT in the anterior nasal cavity up to 6 cm from the 
nostrils (25), it may over-estimate cross sectional areas in the posterior portion of the nasal cavity and pharynx, 
due to partial contribution of the maxillary sinuses (26). 
 
Objectives 
A previous systematic review (27) reported on the subject, however, only studies up to 2010 were included, no 
meta-analysis was performed, and the quality of overall evidence was not assessed with the GRADE (Grading of 
Recommendations Assessment, Development and Evaluation) approach (28). The aim of this study was to 
summarize in a systematic manner evidence on upper airway volume changes induced by RME based on clinical 
studies in growing patients. 
 
Materials and Methods 
Protocol and Registration 
The protocol of the present systematic review was based a priori on Cochrane Handbook for Systematic reviews 
of Interventions 5.1.0. (29). Reporting of this Systematic Review follows the PRISMA statement (30), its 
extension for abstracts (31), and was not registered. 
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Information Sources and Search 
Systematic search of major electronic databases was conducted covering publications in English from inception 
of each database through February 1st, 2016. Electronic searches were performed in Medline via Ovid (1965 to 1st 
February 2016), PREMEDLINE (all available), Old Medline (1946 to 1965), Embase (1947 to 1st February 2016), 
Cochrane Central Register of Controlled Trials (CENTRAL). Unpublished literature was searched electronically 
through ClinicalTrials.gov (www.clinicaltrials.gov) and ISRCTN registry (http://www.isrctn.com/) using the 
terms “expansion”, “airway” and “volume” without any limitations to publication date. Additional hand searching 
of reference lists of relevant articles, grey literature in Google Scholar, and correspondence with experts in the 
field was conducted for location of any additional studies. The search keywords and strategy were developed in 
consultation with a senior health sciences librarian and the search was performed independently by two authors 
(LB and OD). Exact search strategies for MEDLINE via Ovid and Embase are shown in Supplementary Tables 1 
and 2, respectively. 
 
Eligibility Criteria 
The eligibility criteria of included studies were determined a priori (Supplementary Table 3) with the scope of 
evaluating RME-induced volumetric changes in any region of the upper airway, made with any diagnostic 
modality. Eligible studies should report both baseline and post-expansion data. In order to minimize the 
confounding factor of relapse on the immediate volumetric airway changes, it was decided to include only time-
points either immediately following the active expansion period or immediately after the retention period (to a 
maximum of 8 months of retention). Data from follow-up records taken after further non-retained periods, after a 
subsequent orthodontic treatment phase or at long-term reviews were not used in order to avoid confounding. 
Only studies on growing patients (using the cut-off age of 18 years) were included, as skeletal changes produced 
by RME in this period are more consistent. Due to the scarcity of existing studies, we included randomized and 
non-randomized controlled clinical trials and non-randomized cohort clinical studies that included at least 8 
patients.  
  
Study selection and Data Collection  
Study selection and data collection was conducted by two independent blinded authors (LB and OD), with 
discrepancies being resolved by discussion with the last author (AKP). Title and abstract screening was performed 
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blinded (32) by these two authors by grading studies as “yes”, “no” or “maybe” based on the information provided 
by the title and abstract. Full-text was located for all articles graded with “‘yes” or “maybe”, as well as studies 
where no abstract was available, or the information available was inconclusive in reaching a decision. The 
inclusion and exclusion criteria were rigorously applied to the full-text articles and where questions remained, 
efforts were made to contact the authors of the study for. 
Data collection was performed from the same two blinded authors using a customized data extraction 
form (Supplementary Table 4). The primary outcome measure sought was volumetric changes in any region of 
the upper airway. The upper airway was defined as including the nose, nasal passages, paranasal sinuses, oral 
cavity, pharynx (nasopharynx, oropharynx, hypopharynx) (33) and the portion of the larynx above the vocal cords 
(34). Information related to the study samples including sample size, age, gender, as well as patient selection 
criteria were recorded. Details of the type of RME device utilized as well as specifics of the expansion protocol, 
timing, turning frequency, amount of activation, and retention were retrieved from all included studies. The 
modality and technique used to quantify the airway volume, as well as the exact time-points that these were 
recorded were extracted. Measurements were accepted from 3 specific time-points only, defined as: T1, 
immediately prior to insertion of RME appliance; T2, immediately at completion of the active expansion phase; 
and T3, immediately at completion of the retention phase (maximum 8 months). 
 
Risk of bias within individual studies 
The Cochrane Collaboration’s risk of bias tool (35) was used to assess the internal validity of included randomized 
controlled trials. The methodological adequacy of included non-randomized trials was assessed with a customized 
tool that was developed especially for this systematic review based on various appraisal tools (including the 
Newcastle-Ottawa scale) and empirical evidence of bias in orthodontic clinical research (Supplementary Table 5) 
(36-42). The developed checklist comprised 15 individual questions pertaining to four domains: study design, 
study conduct, statistical analysis, and conclusions, with a maximum score of 25. Studies were graded 
descriptively as having overall high (score > 20), moderate (20 ≤ score ≤ 13) or low (score < 13) methodological 
adequacy. However, specific domain questions were also used to determine the strength of the evidence, when 
drawing conclusions from the final data. 
 
Summary Measures 
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The primary outcome of this systematic review was the overall upper airway volume, as this is the most clinically 
relevant outcome for the patient. As mentioned above, results from all diagnostic modalities (including AR, CT, 
etc.) were included, but were analyzed separately. All results were calculated as increment final (post-expansion 
or post-retention) minus initial (pre-expansion) upper airway volume. As many studies reported on the volume of 
various parts of the upper airway, we pooled for each study the total airway volume that was reported. As a 
secondary outcome, we adopted the changes in the volume of each upper airway volume separately and we 
calculated the RME-induced change likewise. For both primary and secondary outcomes, main emphasis was 
given on the results of controlled clinical trials, as these have greater internal validity. Results of uncontrolled 
cohort studies were also reported in order to provide a quantitative overview of the effects of RME on upper 
airway volume, but were interpreted with caution. 
 
Data Synthesis 
As the effects of RME were expected to vary among the included studies according to the different treatment 
protocols, RME appliances, patient characteristics, airway regions, and measurements techniques, a random-
effects model according to DerSimonian and Laird (43) was judged appropriate to encompass this variability (44). 
For all meta-analyses the Mean Differences (MDs) and the associated 95% Confidence Intervals (CIs) were 
calculated. Forest plots were constructed to depict the meta-analysis results and were augmented with contours 
denoting the magnitude of the observed effects. 
Between-trial heterogeneity was quantified with the I2 statistic, defined as the proportion of total 
variability in the results explained by heterogeneity, and not chance (45). The 95% uncertainty intervals (similar 
to CIs) around the I2 were calculated using the non-central χ2 approximation of Q (46). Ninety-five per cent 
predictive intervals (95% PrI) were calculated for meta-analyses of three trials or more, as they incorporate 
existing heterogeneity and provide a range of possible effects for a future clinical setting, which makes them 
crucial for the interpretation of random-effects meta-analyses (47). All analyses were performed using Stata SE 
10.0 (StataCorp, College Station, TX). Statistical significance was set at a two-sided α of 5%, except for test of 
heterogeneity, where α was set at 10%, due to low power (48). 
The overall quality of evidence (confidence in effect estimates) for the primary outcome was rated using 
the GRADE approach (28). The GRADE assessment was based on evidence solely from controlled clinical bias, 
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and not from uncontrolled cohort studies, as the latter are more prone to bias. The minimal clinical important, 
large, and very large effects were conventionally defined (49). 
 
Risk of bias across studies and additional analyses 
In meta-analyses of at least five studies, possible sources of heterogeneity were planned a priori to be sought 
through pre-specified mixed-effects subgroup analyses and random-effects meta-regression with the Knapp and 
Hartung (50) adjustment according to appliance and patient characteristics. If at least 10 studies were included in 
a meta-analysis, reporting biases (including the possibility of publication bias) were assessed using contour-
enhanced funnel plots (51) and Egger’s linear regression test (52). Sensitivity analyses were planned to be 
conducted for meta-analyses of at least 10 studies to assess their robustness according to the study design, the 
improvement of the GRADE classification, and signs of reporting bias. 
 
Results 
Study Selection 
The initial literature search strategy yielded a total of 494 results, while five additional studies were identified 
from the manual search update (Supplementary Table 6). After duplicate removal and initial screening, another 
44 studies were excluded after careful application of the eligibility criteria to their full-texts, leaving a total 22 
papers (15-17, 53-71) (20 unique studies) included in the qualitative synthesis (Figure 1). In two instances, two 
studies pertaining to the same trial were grouped together (55 and 69; 57 and 71). A complete list of included and 
excluded studies with reasons can be found in Supplementary Table 7. From these, a total of 17 papers (15 unique 
studies) were included in the quantitative synthesis, as five studies did not adequately report outcome data. 
 
Study Characteristics  
The characteristics of the 20 studies included in this systematic review are given in Supplementary table 8-10. As 
far as study design is concerned, one was a randomized controlled clinical trial (53), two were prospective 
controlled clinical trials (17, 62), and the remaining 17 were cohort studies (2 retrospective (56, 60) and 15 
prospective (15, 16, 54, 55, 57-59, 61, 63-68, 70) in nature). Data was collected for a total of 483 treated subjects 
and 55 controls (median of 20 treated and 20 control patients per study). Samples were mixed for size, gender and 
age of participants (Supplementary table 8). Mean initial age of treated patients ranged from 7.5-14.5 years with 
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an average of 11.9 years. Inclusion criteria varied, however all involved patients had transverse maxillary 
deficiency. In addition, posterior cross-bites were compulsory in ten studies (15, 16, 55, 57, 59-62, 66) and 
optional in two studies (54, 58). The level of skeletal maturation of patients prior to expansion treatment was 
determined by using cervical maturation index in three studies (58, 63, 64) or hand-wrist radiographs in one study 
(64). Separation of the maxillary halves by RME was verified, either by radiographic film (15) or recorded as 
clinical observation of midline diastema formation (64).  
The expansion appliance used in the studies included banded RME in 9 studies (53-56, 58-60, 64, 65), 
bonded RME in 10 studies (15, 16, 57, 58, 61-66), while a study compared banded, bonded and Haas-style RME 
appliance groups (64). The cast cup design was used in a study (67) and two studies did not clearly describe type 
of appliance used (68, 70). Duration of active expansion varied between studies, representing varied needs of the 
individual patients. Reported total expansion distances at the screw ranged from 2.7-10.0 mm. While the 
expansion protocol was well defined in most studies, it was not reported in three of them (57, 58, 65). Retention 
techniques varied, with keeping the expander in place passively for some period being the most commonly used 
practice in 12 studies (15, 17, 53-55, 60, 62-64, 66, 68, 70), four studies did to outline a retention scheme at all 
(59, 61, 65, 67), while the rest of the studied provided inadequate information (16, 56-58). 
The volume of seven upper airway regions was evaluated in the included studies: nasal cavity, anterior 
nasal cavity, maxillary sinus, nasopharyngeal, oropharyngeal, hypopharyngeal, and palatal volume. Within the 
nasal cavity, measurements by both AR and CT were considered. Nasal volume measures by AR were considered 
with decongestant or without decongestant (also known as basal condition). 
All studies recorded baseline volume measurements immediately prior to commencement of RME (T1), 
five studies (59, 65, 67, 68, 70) assessed these volumes again immediately after active expansion (T2) and fifteen 
did so after the retention period (T3). The modalities used to quantify airway volume included AR in 6 studies 
(15-17, 53, 62, 64), CBCT in 8 studies (54, 55, 57-59, 67, 68, 70), CT in 6 studies (16, 56, 60, 61, 63, 65), surface 
laser scanning in one study (60), and photogrammetry in one study (66). 
 
Risk of Bias within Studies 
The risk of bias assessment for all included randomized and non-randomized trials is given in Tables 1 and 2, 
respectively. The inter-examiner consensus was that the risk of bias was high for all included studies. Most 
common biases observed were selection bias, sampling bias (due to differing inclusion / exclusion criteria), 
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inexistent or problematic randomization, and allocation concealment. Blinding of treatment providers and patients 
was not feasible, as RME use was obvious, while only one randomized trial (58) attempted during outcome 
assessment. Performance bias due to differences in care between groups was not deemed to be substantial within 
individual studies. 
 
Results of individual studies, synthesis of results, and risk of bias across studies 
The results of all included studies and the various upper airways volumes that were measured are listed in 
Supplementary Tables 9 and 10, respectively. 
 
Total airway volume 
The results of data synthesis regarding the primary outcome of total airway volume can be seen in Table 3. As 
however, no controlled clinical trials were available results are based solely on cohort studies of only treated 
patients and therefore should be interpreted with caution as a quantitative overview of the RME-induced changes 
on the upper airway. As far as total airway volume is concerned patients treated with RME showed a significant 
increase both post-expansion (5 studies; increase from baseline: 1218.3 mm3; 95% CI: 702.0 to 1734.6 mm3), 
which did not seem to considerably diminish after the retention period (11 studies; increase from baseline: 1143.9 
mm3; 95% CI: 696.9 to 1590.9 mm3) (Figure 2). 
 
Airway volumes of the various regions 
As far as changes in the various upper airway regions are concerned, the results of data synthesis are given in 
Tables 4-5 and Supplementary table 12. 
 The effect of RME on the nasal airway volume could be assessed both from controlled clinical studies 
and cohort studies of treated patients. As far as controlled studies using AR are concerned, RME was associated 
with a statistically significant increase in the nasal volume compared to untreated patients both after expansion 
and after the retention period (Table 4). Additionally, this increase was consistent in both basal and decongested 
conditions of the nasal cavity. Assessment of the results with the GRADE approach indicated that the quality of 
evidence for this increase was “very low”, due to the nature of the included studies and serious methodological 
limitations (Table 5). 
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Additionally, based on cohort studies of treated patients RME was associated with increased nasal cavity 
volume measured by CT, AR in the basal condition, and AR in the decongested condition, although this was 
statistically significantly only for the latter. Additionally, this increase seemed to diminish slightly from post-
expansion (increase of 69.0 mm3) to post-retention (25.8 mm3), although remaining statistically significant. 
Furthermore, RME was associated with an increase in the CT-measured volume of the velopharynx 
(1201.2 mm3 post-retention), the nasopharynx (662.3 mm3 post-expansion; 396.7 mm3 post-retention), the 
oropharynx (390.4 mm3 post-expansion; 70.7 mm3 post-retention), and the hypopharynx (170.0 mm3 post-
retention). However, most of these volumes were not statistically significantly increased from baseline, 
presumably due to the limited number of contributing studies, their small samples, and the resulting low statistical 
power. In any case, caution is warranted in the interpretation of these findings, as no control groups were included 
to factor out the normal growth of the upper airways.  
 
Additional Analyses 
Due to the limited number of studies in the meta-analyses, subgroup analyses could be performed only for two 
outcomes: the total airway volume and the total nasal cavity volume, both measured post-retention with CT 
(Supplementary Table 13). No significant effect on the RME-induced volume increase could be found for patient 
age, patient sex, and appliance design. 
As far as the assessment of reporting biases (including the possibility of publication bias is concerned) 
only one meta-analysis with at least ten studies was included, assessing the total airway volume post-retention 
with CT. As can be seen in the contour-enhanced funnel plot (Figure 3) and the results of Egger’s test, no 
considerable indications of reporting biases could be found (Supplementary table 13). 
Finally, although various sensitivity analyses were initially planned, these could not be robustly 
performed, due to the small number and the characteristics of the included studies. The only sensitivity analysis 
that could be performed was the assessment of difference in the effects between prospective and retrospective 
studies. Prospective studies tended to report considerably smaller total volume increases after RME compared to 
retrospective studies (difference=-560.9 mm3; 95% CI=-2139.5 to 1017.8 mm3), although this was not statistically 
significant (P=0.442).  
 
Discussion 
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Summary of Evidence 
This systematic review summarized evidence on the effect of RME on the upper airway volume from 
clinical studies in humans. However, the results have to be considered with caution, due to the limited number of 
existing studies and serious methodological issues in their conduct. 
In a previous systematic review, Baratieri et al. (27) investigated the long term effects of RME on airway 
dimensions and functions. The authors included studies reporting 2D linear measurements from xrays, nasal 
volume and minimal cross sectional areas from CBCTs and AR and functional parameters such as nasal airway 
resistance and airflow as measured with rhinomanometry. They concluded that moderate evidence exists as to 
improvement of nasal breathing after RME in growing patients and these results are stable for at least 11 months 
after treatment. However, in the present systematic review we expanded the selection criteria in studies that not 
only evaluated volumetric changes in the nasal cavity but also in all upper airway areas. Moreover, studies 
reporting results after a retention period of more than 8months were excluded from our study in an attempt to 
reduce the effect of growth and evaluate the net result of RME. 
The main finding of the present review was that RME is associated with an increase in the total volume 
of the upper airway as well as the volume of the various regions of the upper airway. This increase seemed to be 
consistent to the various measurement modalities used in the studies and slightly diminished during the retention 
period. Although the type of expander appliance used varied amongst studies, no considerable differences were 
found based on appliance design. Additionally, some inconsistency existed across studies with regards to the 
definition of airway region borders. International consensus on region limits does not currently exist, particularly 
the landmarks or planes used to demarcate the junction of the nasal cavity and nasopharynx and between regions 
of the pharynx. This can lead to discrepancies between studies referring to similar airway spaces, although this 
has a smaller effect on the primary outcome of this review, which was the total airway volume. Also, various 
study designs were included, which have been shown to be associated with different extents of bias (41, 42), and 
this might explain part of the observed variability in the results. 
When considering the nasal cavity volume, very low quality evidence according to the GRADE approach 
indicates that RME is associated with a modest but consistent increase in volume measured by AR (Table 5). This 
is seen in both basal and decongested conditions, while uncontrolled CT-based evidence from cohort studies 
seems to back up this notion (Supplementary table 12). Amongst AR studies, there seemed to be a possible 
correlation between the initial subject age and the magnitude of the effect size, with younger initial age producing 
larger effect sizes. This descriptive trend was demonstrated in both decongested and non-decongested groups. 
Explanation is likely due to the reduced resistance in the bony sutures. Thus, nasal cavity volume increase might 
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be more pronounced in growing young subjects. Additionally, RME appears to increase the volume of the anterior 
nasal cavity based on CT measurements. The implications of dimensional increases in this zone are important, as 
it represents the region of greatest nasal airflow-resistance in most people (72) and a number of authors attribute 
improvements in nasal breathing to nasal valve enlargement (11). 
There is much debate over the validity of CT and CBCT volumetric analysis in the measurement of 
function airway spaces. Topical contrast agents have been suggested to improve accuracy in defining soft tissue 
surfaces (73), an alternative that was not used in any of the included studies. Only a few studies that use CBCT 
for airway volume calculation describe using any form of standardization of patient positioning and protocol 
during image capture. This is particularly relevant in the retrospective studies where airway standardization at 
capture would be unlikely to have occurred, unless future airway assessments were foreseen at the time. Vertical 
position in conjunction with a neck-brace and apparatus to orient natural head posture among other standards of 
breathing, swallowing and occlusion has been incorporated in order to obtain data with minimized variation (54). 
It has been shown that airway dimensions change according to head posture (74) and these changes were attributed 
to gravity acting on the relaxed soft palate, tongue and hyoid bone positions. More precisely, anteroposterior 
dimensions at the level of the velopharynx and sagittal cross-sectional areas of both velopharynx and oropharynx 
were decreased in response to body position change from upright to supine when measured in lateral cephalograms 
(75), indicating another factor that might increase heterogeneity amongst studies . 
Additionally, pharyngeal airway space (PAS) dimensions are closely related to both sagittal and vertical 
skeletal pattern. When CBCT reconstructions were used to evaluate linearly and volumetrically the dimensions 
of PAS in children with different growth patterns, it was found that as the SNB angle was decreasing, linear 
measurements of PAS at the level of the uvula, uvula tip, mandibular line and back of the tongue also decreased. 
This trend was also consistent in regards to airway volume, airway area and minimum axial area. Further 
investigation on the effect of vertical facial type on PAS revealed that the hyperdivergent growth pattern was 
associated with reduced linear values at the level of the uvula tip. Conclusively, dimensions were significantly 
reduced in hyperdivergent patients with retrognathic mandibles (76). In the present systematic review, included 
studies did not provide information on grouping patients according to initial anteroposterior or vertical 
relationships. As airway dimensions differ according to the skeletal pattern, an additional confounding factor at 
the baseline of the included studies increases heterogeneity of the sample and possibly creates individual 
variations in patients’ airway response to RME. 
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The ethical questions raised regarding the use of a control group relate to withholding RME treatment 
from a group of patients who are at an appropriate age for it for the purpose of acting as a control and to radiation 
exposure. Depending on the settings, full CBCT images of the head can produce dosages from 68-368 μSv (77). 
Keeping in mind the stochastic nature of the effect of ioniziong radiation (78, 79), it might not be appropriate to 
subject a control group to multiple radiation exposures in relatively close succession.  
Although cross-sectional area and respiratory indices were not considered in this review, the implication 
of increases in volume in the airway is the potential for improvements in compromised functional respiratory 
features. Further research in this area is required in order to provide better evidence on the normal growth changes 
in volumetric parameters during the growth period and possible respiratory effects that may occur from them. 
Given technological advancements in diagnostics and accuracy, it is hoped that careful attention to experimental 
design and conduct will allow for future results of sufficient strength to answer these questions more definitively. 
As far as the generalizability/applicability of results is concerned, the results of this review might be 
applicable to the average growing patient with transverse maxillary constriction, as the eligibility criteria used for 
study selection were broad and most included studies were conducted in pragmatic conditions. As a random-
effects model was used for the meta-analysis, the 95% prediction intervals should be used for interpretation; these 
incorporate existing heterogeneity and provide the range of possible effects of RME on airway volume. However, 
caution should be exerted during the interpretation of the results, due to the high risk of bias and the fact that 
subgroup analyses could not be adequately used to describe the ideal candidates for RME. 
 
Strengths and Limitations 
The strengths of this systematic review include the extensive literature search, the duplicate and blinded review 
procedures, and the assessment of the quality of evidence with the GRADE approach. All procedures of the 
qualitative synthesis were conducted under the guidelines of the Cochrane Handbook (29) and the PRISMA 
statement (30), while attempts were made to minimize bias during quantitative synthesis (80), and no signs of 
reporting bias were identified.  
The main shortcoming of this systematic review is the limited number of existing studies, most of which 
are non-randomized studies with serious methodological limitations. Additionally, most existing studies do not 
have a control group to reduce the confounding effect of normal growth. As the aim of this review was to 
determine the immediate effect of RME on airway volume, it was assumed that within the short experimental 
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period of up to 8 months of the included studies the degree of growth effects occurring would be small. The 
dimensions of children’s airways between 6 and 15 years increase at a normal rate of 0.032 cm2/year (81) 
indicating that the volume increase found in the present study cannot be attributed to growth alone. However, this 
cannot be completely ruled out and future well-designed prospective controlled studies are needed to confirm this 
finding. Additionally, it was not possible to correlate overall the volumetric changes observed with the amount of 
RME activation because complete data on amount and appliance type was not provided by all studies. Finally, 
while sources of heterogeneity and robustness of the results were planned to be checked with subgroup and 
sensitivity analyses, respectively, most of these analyses could not be performed. The clinical heterogeneity at the 
level of assessed appliances, expansion protocols, chosen outcomes, and measurement methods is evident and 
precludes any robust clinical suggestions on the effect of RME on upper airway volume. 
 
Conclusions 
Evidence from existing controlled and uncontrolled clinical studies indicates that RME in growing patients with 
transversal maxillary constriction might be associated with a short-term increase in the total upper airway volume 
and most of the separate airway volumes. However, the results should be interpreted with caution, due to the small 
number of included trials and serious methodological issues, which might affect the risk of bias. Future well-
conducted prospective controlled clinical studies on growing patients are needed in order to recommend the use 
of RME to increase the upper airway volume in an evidence-based and predictable way.  
 
Supplementary material 
Supplementary material is available at European Journal of Orthodontics online. 
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Figure Legends 
Figure 1. Flowdiagram for the identification and selection of studies. 
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Figure 2. Contour-enhanced forest plot for the meta-analysis of the primary outcome (post-pre total airway 
volume change in mm3) in the patients treated with rapid maxillary expansion. Contours indicate 
increasing effect magnitude from the middle line-of-no-effect outwards (±2000.0 mm3, ±4000.0 mm3, 
±8000.0 mm3 used as cut-offs to indicate moderate, large, and very large effects). Studies to the right 
indicate that the upper airway volume was increased compared to baseline. RME, rapid maxillary 
expansion; CI, confidence interval; NR, not reported. 
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Figure 3. Contour-enhanced funnel plots for the assessment of reporting biases (including small-study effects 
and the possibility of publication bias). 
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Table 1. Risk of bias of the included randomized clinical trial. 
Study 
Adequate sequence 
generation 
Allocation 
concealment 
Blinding 
Incomplete outcome 
data 
Selective
reporting 
Blinding of outcome 
assessment 
Other bias 
Kabalan et al 2015 (52) Low risk High risk High risk Low risk Low risk High risk Moderate risk 
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Table 2. Risk of bias assessment of the included non-randomized studies. 
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Methodological 
adequacy 
Almuzian et al 2016 (66) 0 2 2 1 0 2 1 2 2 0 1 1 2 2 1 18 Moderate 
Azaredo 2014 (67) 0 2 1 2 0 2 1 1 2 0 1 1 0 1 1 16 Moderate 
Babacan et al. 2006 (15) 0 2 1 1 1 2 0 2 2 0 1 1 1 1 1 16 Moderate 
Cappellette et al. 2008 (17) 0 2 1 2 2 2 0 1 2 0 0 1 1 1 1 16 Moderate 
Chang 2011 (68); Chang et al. 2013 (54) 0 2 1 1 0 2 1 2 2 0 1 1 2 2 1 18 Moderate 
Cordasco et al. 2012 (59) 0 2 1 1 0 1 1 2 2 0 1 1 1 1 1 15 Moderate 
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Doruk et al. 2007 (16) 0 2 1 1 0 2 0 1 1 0 1 1 1 2 1 14 Moderate 
Görgülü et al. 2011 (60) 0 2 1 1 0 1 0 1 2 0 1 1 0 1 1 12 Low 
Haralambidis et al. 2009 (62) 0 2 1 1 1 2 0 2 2 0 1 1 1 1 1 16 Moderate 
Kabalan et al 2015 (52) 1 1 2 1 2 2 1 1 2 0 1 1 1 1 1 18 Moderate 
Li et al 2015 (69) 0 2 2 2 0 2 1 2 2 0 0 1 0 1 1 16 Moderate 
Marini et al. 2007 (65) 0 2 1 2 0 2 0 1 1 0 0 1 2 1 1 14 Moderate 
Oliveira De Felippe et al. 2008 (63) 0 2 1 2 1 2 1 2 2 0 1 1 1 1 1 18 Moderate 
Palaisa et al. 2007 (64) 0 1 1 1 0 1 1 0 2 0 1 1 0 2 1 12 Low 
Pangrazio-Kulbersh et al. 2012 (57) 1 2 1 1 1 2 0 1 2 1 1 1 1 1 1 17 Moderate 
Ribeiro 2011 (70); Ribeiro et al. 2012 (56) 0 1 1 1 1 1 0 1 1 0 0 1 1 1 1 11 Low 
Smith et al. 2012 (55) 0 2 1 1 0 2 1 2 2 0 1 1 2 1 1 17 Moderate 
Sökücü et al. 2010 (61) 0 2 1 1 2 2 0 2 2 0 1 1 2 1 1 18 Moderate 
Zeng & Gao 2013 (54) 0 2 1 1 0 2 0 2 2 0 0 1 2 1 1 15 Moderate 
MAXIMUM 1 2 2 2 2 2 1 2 2 1 1 1 2 2 1 25  
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Table 3. Results of meta-analyses regarding the main outcome (total airway volume in mm3) only in treated groups. 
Measurement Timing Studies Change (95% CI) P 95% Predictive Interval   I2 (95% interval) 
CT Post-expansion 5 1218.30 (701.97,1734.63) <0.001 379.92,2056.68   0% (0%,64%) 
CT Post-retention 11 1143.87 (696.85,1590.90) <0.001 -26.97,2314.72   63% (14%,79%) 
CI, confidence interval; CT, computed tomography; AR, acoustic rhinometry. 
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Table 4. Results of meta-analyses on total nasal cavity volume in mm3 from studies with 
untreated controls (change in treated patients minus change in untreated patients)*. 
Measurement Timing Studies MD (95% CI) P value 
AR-basal condition post-expansion 1 44.00 (32.65,55.35) <0.001 
AR-basal condition post-retention 1 19.00 (7.80,30.20) 0.001 
AR-decongested condition post-expansion 1 71.00 (57.28,84.72) <0.001 
AR-decongested condition post-retention 1 23.00 (9.45,36.55) 0.001 
MD, mean difference; CI, confidence interval; AR, acoustic rhinometry. 
* I2 with its associated 95% intervals and 95% predictive intervals could not be calculated. 
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Table 5. Summary of Findings table according to the GRADE approach for the primary outcome results from studies with untreated control group.  
Patients: patients with posterior crossbite or an anteriorly constricted maxillary arch in need of maxillary expansion 
Settings: university clinic (Turkey) 
Intervention: conventional of fan-type rapid maxillary expansion 
Comparison: patients with ideal occlusion that did not receive any treatment 
  Anticipated absolute effects   
Outcomes, no of participants (studies) 
Relative effects 
(95% CI) 
Observation RME 
Quality of evidence 
(GRADE) 
What happens 
Nasal cavity volume measured by AR (basal) 
Follow-up: post-expansion; 23.3 days 
45 patients (1 study) 
MD 44.0 
(32.7 to 55.4) 
5.0 mm3 
increase 
49.0 mm3 increase 
(37.7 to 60.4 mm3 increase) 
⊕⊝⊝⊝ very lowa 
Probably 
increases nasal 
cavity volume 
Nasal cavity volume measured by AR (basal) 
Follow-up: post-retention; 6.2 months 
45 patients (1 study) 
MD 19.0 
(7.8 to 30.2) 
6.0 mm3 
increase 
25.0 mm3 increase 
(13.8 to 36.2 mm3 increase) 
⊕⊝⊝⊝ very lowa Same 
Nasal cavity volume measured by AR (decongested) 
Follow-up: post-expansion; 23.3 days 
45 patients (1 study) 
MD 71.00 
(57.3 to 84.7) 
2.0 mm3 
decrease 
2.0 mm3 decrease ⊕⊝⊝⊝ very lowa Same 
Nasal cavity volume measured by AR (decongested) 
Follow-up: post-retention; 6.2 months 
45 patients (1 study) 
MD 23.00 
(9.5 to 36.6) 
2.0 mm3 
increase 
2.0 mm3 increase ⊕⊝⊝⊝ very lowa Same 
CI, confidence interval; AR, acoustic rhinometry; MD, mean difference; RME, rapid maxillary expansion. 
GRADE starts from "low", due to the inclusion of non-randomized studies. Downgraded further by one point for high risk of bias.
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Supplementary Table 1. Medline search strategy via Ovid  
Step Keyword (hits) 
1 RME.mp (637) 
2 rapid maxillary expan$.mp (554) 
3 rapid palatal expan$.mp (284) 
4 maxillary expan$.mp (814) 
5 skeletal expan$.mp (36) 
6 palatal expan$.mp (2087) 
7 transverse expan$.mp (71) 
8 orthodontic expan$.mp (50) 
9 orthop?edic maxillary expan$.mp (6) 
10 transpalatal distract$.mp (20) 
11 rapid maxillary disjunction.mp (0) 
12 rapid palatal disjunction.mp (1) 
13 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 
OR 10 OR 11 OR 12 (2651) 
14 air$.mp (352190) 
15 volum$.mp (479228) 
16 14 OR 15 (795866) 
17 13 AND 16 (216) 
18 Limit 17 to English language (199) 
 
 
 
 
 
Supplementary Table 2. Embase search strategy. 
Step Keyword (hits) 
1 Maxillary (45918) 
2 Palatal (10714) 
3 Rapid (574980) 
4 Expan* (320271) 
5 Skeletal (219238) 
6 Orthodontic (35390) 
7 Orthop?edic (166763) 
8 Transverse (59857) 
9 Transpalatal (488) 
10 Distract* (25324) 
11 Disjunction (2069) 
12 #1 AND #3 AND #4 (842) 
13 #2 AND #3 AND #4 (467) 
14 #1 AND #4 (2099) 
15 #1 OR #2 (53992) 
16 #4 AND #5 AND #15 (443) 
17 #2 AND #4 (824) 
18 #4 AND #8 AND #15 (398) 
19 #4 AND #6 (1374) 
20 #1 AND #4 AND #7 (27) 
21 #9 AND #11 (1) 
22 #1 AND #3 AND #11 (18) 
23 #2 AND #3 AND #11 (11) 
24 #12 OR #13 OR #14 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 (2862) 
25 air* (634013) 
26 volum* (837843) 
27 #25 OR #26 (1411050) 
28 #24 AND #27 (331) 
29 #24 AND #27 AND [humans]/lim AND [English]/lim (257) 
 
 
 
 
 
 
Supplementary Table 3. Eligibility criteria used for the study selection 
Category Inclusion criteria Exclusion criteria 
Participant characteristics 
Studies with at least 8 human growing patients (age ‹ 18years) with 
constricted maxilla (unilateral or bilateral posterior crossbite) in need for 
orthopaedic expansion 
Clinical trials with less than 8 patients 
Patients with craniofacial syndromes and/or cleft lip and palate 
Medically compromised patients 
Patients with temporomandibular joint disorders 
Animal studies 
Intervention 
Jackscew-based Rapid Maxillary Expansion (RME) 
RME appliance left in place for retention (maximum 8 months post-
RME) 
Other concurrent orthodontic treatments received that may influence 
results (eg. orthodontic fixed appliances) 
Slow maxillary expansion 
Expansion with removable appliances 
Comparison 
 Same patients compared at baseline and after RME 
(immediately or maximum 8 months post-RME) 
 Patients treated with surgically assisted rapid maxillary 
expansion 
 Untreated controls 
Follow-up measurements taken more than 8 months after expansion 
Follow up measurements not taken either immediately after active 
expansion or immediately after retention period, thus involving significant 
period without transverse retention 
Outcome 
Studies providing quantitative volumetric measurements of the upper 
airways from: 
 Acoustic rhinometry 
 Computed tomography 
 Cone beam computed tomography 
 Digital photogrammetric technique 
Studies providing only linear cephalometric measurements 
Studies providing only study model linear measurements 
 
Study design 
Randomized controlled clinical trials 
Prospective or retrospective controlled clinical trials 
Clinical cohort studies 
Case reports 
Review articles 
Unsupported opinions 
Interviews 
Commentaries 
Conference abstracts 
Replies to the editor/author 
 
 
 
 
Supplementary Table 4. Data extraction form. 
Item 
Study Name:  
Author & Year: 
Date form completed: 
Sample Group (age, gender, ethnicity, etc): 
Control/Comparator Group (age, gender, ethnicity, etc): 
Methods of recruitment of participants: 
Inclusion Criteria: 
Exclusion Criteria: 
Informed consent obtained? (Yes/No/Unclear) 
Ethical approval (Yes/No/Unclear) 
Funding (if stated)  
Statistical methods and their appropriateness (if relevant): 
Principal health problem or diagnosis (if relevant): 
Other health problem/s (if relevant): 
Purpose of study (if stated): 
Treatment received/receiving: 
Volume Measurement Technique(s) used: 
Region that Volume Measured: 
Definition/Boundaries of Measured Region(s): 
Other Measurements Taken: 
RME Technique Used: 
Expansion Appliance Details: 
Activation Protocol: 
Activation End-point: 
Retention Protocol (method & timing): 
T2 Measurement Time-Point: 
T3 Measurement Time-Point: 
AR Specifics (measurement technique): 
CT Specifics (measurement & calculation technique): 
3D Photographic/ Scanning Specifics (measurement & calculation technique): 
Error Assessment: 
Comments: 
AR, acoustic rhinometry; CT, computed tomography; 3D, three-dimensional. 
 
 
 
 
 
 
Supplementary Table 5. Risk of Bias Assessment Tool. 
1. Study Design 
 
a. Randomization to groups (0/1) 
  
0 = No randomization or inadequate randomization 
  
1 = Adequate randomization to groups  
 
b. Sample Described (0/1/2) 
  
0 = No details provided of study sample 
  
1 = Some descriptive statistics of study sample given but incomplete 
  
2 = Sample adequately described & statistics provided (age, gender etc) 
 
c. Selection Criteria (0/1/2) 
  
0 = No details on how study participants were recruited 
  
1 = Some information provided on subject inclusion & exclusion but no bias reduction methods 
used or described 
  
2 = Inclusion & exclusion criteria disclosed & bias reduction methods implemented (ie. 
Consecutive selection of patients) 
 
d. Sample Size (0/1/2) 
  
0 = Sample size <8 
  
1 = Sample size 8-25 
  
2 = Sample size >25 patients 
 
e. Controls Used (0/1/2) 
  
0 = No control 
  
1 = Attempt made to use some form of control/comparator group 
  
2 = A matched, untreated control group used 
 
f. Follow-up Definition & Length (0/1/2) 
  
0 = No follow-up period or study end-point given 
  
1 = Follow-up period poorly defined or inadequate 
  
2 = Clear description of initiation of Tx and follow-up time & how statistics were computed 
2. Study Conduct  
 
a. Dropouts Mentioned (0/1) 
  
0 = No description of subject drop-outs or lost to follow-up, or excessive >20% drop-out during 
follow-up 
  
1 = No dropouts or acknowledgement of dropouts 
 
b. Intervention Protocol Described (0/1/2) 
  
0 = No details given on appliance or its use 
  
1 = Details given on expansion appliance and activation protocol clearly described 
  
2 = Details on expansion appliance and activation protocol clearly described, along with amount 
of activation or end-point for activation 
 
c. Measurement Defined (0/1/2) 
  
0 = No description of how volumes or changes were quantified 
  
1 = Partial measurement details given 
  
2 = Clear description of volume measurement technique including apparatus used & technique 
 
d. Assessor Blinding (0/1) 
  
0 = No blinding used in assessing to outcomes 
  
1 = Attempt to blind outcome assessors 
 
e. Reliability/Error Testing (0/1) 
  
0 = No error testing or method error provided 
  
1 = Reporting & statistical examination of errors 
3. Statistical Analysis 
 
a. Appropriate Statistics (0/1) 
  
0 = Statistical methods not disclosed or inappropriate methods used 
  
1 = Correct & judicious use of statistical tests & avoidance of type I errors 
 
b. Confounders Analyzed (0/1/2) 
  
0 = Not discussed 
  
1 = Confounders discussed but no statistical adjustments made in analysis 
  
2 = Acknowledgement of, and statistical adjustment made for confounding variables 
 
c. Presentation of Data (0/1/2) 
  
0 = Poor presentation of data with key variables omitted 
  
1 = Majority of data displayed, only „grouped‟ values given rather than individual subject results 
  
2 = Clear presentation of data, point estimates, variances, change scores & individual subject 
data provided 
4. Conclusion 
 
a. Reasonable Conclusion for Study Power (0/1) 
  
0 = No conclusion made, or unreasonable conclusions given study design 
  
1 = Reasonable statement of study meaning in light of limitations 
Tx, treatment. 
 
 
 
 
Supplementary Table 6. Results of the literature searches performed in each database. 
Database Date searched Results 
MEDLINE (through Ovid) February 1
st
, 2015 199 
Embase February 1
st
, 2015 257 
PreMEDLINE February 1
st
, 2015 25 
CENTRAL February 1
st
, 2015 13 
OLDMEDLINE February 1
st
, 2015 0 
Manual search in Google Scholar for additions February 1
st
, 2016 5 
 
 
 
 
 
 
 
Supplementary Table 7. Studies Excluded with Reasons (total: 44 studies). 
Study Database(s) Found Rating after full-text review Reason 
Al-Taai et al. 2015 PML NO 2 
Altug-Atac, et al. 2010  Hand NO 2 
Atac et al 2011  E NO 2 
Bicakci et al. 2005 ML, CEN, E NO 2 
Bouserhal et al. 2014  ML, E NO 2 
Caprioglio et al. 2014 ML, E NO 3 
Chiari et al. 2009 ML, E NO 2 
Compadretti et al. 2006 ML, E NO 3,4,5 
Compadretti,Tasca, et al. 2006 ML, E NO 3,4,5 
Cozza et al. 2007 E NO 2 
De Felippe et al. 2009 ML, E NO 3,7 
Doruk et al. 2004 ML, E NO 2 
El & Palomo 2014 ML NO 3,4,5 
Enoki et al. 2006 ML, E NO 2 
Fastuca et al. 2014 PML NO 7 
Ghoneima et al. 2010 ML, E NO 2 
Giuca et al. 2009 ML, E NO 2 
Gohl et al. 2010 ML, E NO 3,4,5 
Gracco et al. 2010 ML, E NO 3 
Gray & Brogan 1972 ML NO 2 
Gray 1975 E NO 2 
Iwasaki et al. 2013 ML, E NO 3,4,5 
Iwasaki et al. 2012 ML, E NO 2 
Iwasaki et al. 2014 ML, E, PML NO 2 
Kurt et al. 2010 ML NO 2 
Matsumoto et al. 2010 ML, E NO 2 
Motro et al. 2015 E NO 10,11 
Neveus et al. 2014 E NO 8 
Petit, 1987 ML NO 1 
Pirelli et al. 2010 ML, E NO 2 
Primozic, Baccetti et al. 2013 ML NO 4,6 
Primozic, Ovsenic et al. 2009 ML, E NO 6 
Primozic, Perinetti et al. 2013 ML, E NO 6 
Primozic, Richmond et al. 2013 E NO 6 
Rondeau, 2004 ML NO 1 
Subtelny, 1980 ML NO 1 
Tecco et al. 2005 E NO 2 
Timms, 1987 ML NO 1 
Timms, 1995 ML NO 1 
Timms, 1984 ML, E NO 2 
Timms, 1986 ML NO 1 
Warren et al. 1987 ML, E NO 2 
Wertz, 1968 ML, E NO 2 
Zhao et al. 2010 ML, E NO 3,4,5 
PML, PreMEDLINE; Hand, handsearching; E, Embase; ML, MEDLINE; CEN, Central. 
    
Key to reason for exclusion of study at full-text review 
1. Not a clinical study 
2. Not assessing or measuring upper airway volume(s) 
3. Follow-up period too long (>8months) 
4. Follow-up period involves significant period without any retention 
5. Additional treatment performed besides RME during study period 
6. Does not use RME protocol (ie. SME, SRME) 
7. Duplicate sample or sample data used 
8. Only baseline volume(s) reported 
9. Could not be located in English 
10. Sample included patients over 18 years 
11. Appliance type not consistent with inclusion 
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Supplementary Table 8. Study Design, Participants, Intervention, Comparators and Outcome (PICO) of Included Studies. 
Study Country Study Design Treatment Group Control Inclusion Criteria Intervention Outcome (Volume) 
Almuzian et al. 2016 
(67) 
UK Prospective cohort 
study 
17 Pts 
(8 boys, mean age 
12.4yrs 
Range:10.5-14.08yrs) 
(9 girls, mean age 
12.8yrs 
Range: 10-16.25yrs) 
No Caucasians, age 10-16yrs, 
Normal body mass index 
Constricted maxillary arch 
Unilateral or bilateral posterior 
crossbite 
No previous surgery 
(tonsilar, nasal, adenoid, head and 
neck) 
No craniofacial deformity 
No previous orthodontic treatment 
Less than 5° head and craniocervical 
orientation between pre-treatment and 
post-treatment  
RME (cast 
cup) 
Lower nasal cavity 
Upper nasopharynx 
Retropalatal 
Right and left sinus 
Azaredo 2014 (68) Brazil Prospective cohort 
study 
33 Pts 
(11 boys, 22 girls) 
mean age 
10.7±1.63yrs) 
No Transverse maxillary deficiency 
Upper first permanent molars and first 
premolars or first primary molars 
present and fully erupted 
Age 7-14 years old 
No previous orthodontic treatment 
No congenital malformations 
No tooth agenesis 
No periodontal problems 
RME 
(Hyrax or Hass 
as assumed 
by ethics 
approvals in 
the 
appendices) 
Total upper airway 
Babacan et al. 2006 
(15) 
Turkey Prospective cohort 
study 
10 Pts 
(5 boys, 5 girls) 
mean age 12.3 ± 
0.82yrs 
No No history of nasal disease 
No previous tonsillar, nasal or 
adenoidal surgery 
Presence of adequate nasal cavity 
space confirmed by anterior 
rhinoscopic examination by 
otolaryngologist 
Skeletal maxillary constriction with 
bilateral posterior crossbite 
RME (bonded) Nasal cavity 
Cappellette et al. 2008 
(17) 
Brazil Prospetive controlled 
clinical trial 
50 Pts 
(27 boys, 23 girls) 
age range 4-14 yrs 
 
20 Pts 
(11boys , 9girls) 
Age 4-11 yrs 
Without Maxillary 
hypoplasia 
Mouth breathing pts 
Age 4-14yrs 
Clinical diagnosis of maxilla hypoplasia 
by an orthodontist 
RME Nasal cavity 
 
Chang 2011 (69); USA Prospective cohort 14 Pts No Young orthodontic pts (<16yrs), RME (banded) Retropalatal 
 
 
 
 
Chang et al. 2013 (55) study (5 boys, 9 girls) 
mean age 12.9ysr 
(range 9.7-16yrs) 
Unilateral or bilateral posterior 
crossbites, Pts scheduled to receive 
RME as part of comprehensive 
orthodontic treatment 
Retroglossal 
Total upper airway 
Cordasco et al. 2012 
(60) 
Italy Retrospective cohort 
study 
8 Pts 
(3males, 5 girls) 
mean age 9.7yrs 
(SD 1.41yrs) 
No Constricted maxillary arch 
All first permanent molars erupted, 
Unilateral or bilateral posterior 
crossbite 
RME (banded) Anterior Nasal 
cavity 
Posterior Nasal 
cavity 
Total Nasal cavity 
Darsey et al. 2012 (59) USA Prospective cohort 
study 
30 Pts 
(10 boys, 20 girls) 
mean age 13.8yrs 
(range 9-20y) 
Group 1: 9-14yrs 
(n=18, 6 boys,12 girls) 
Group 2: 15-20yrs 
(n=12, 4 boys, 8 girls) 
No Patients with bilateral posterior 
crossbites 
Determined to require bilateral 
maxillary expansion by orthodontist 
 
RME (banded) Maxillary sinuses 
Doruk et al. 2007 (16) Turkey Prospective cohort 
study 
10 Pts 
(4 boys, 6 girls) 
age range 12-14yrs 
 
No Maxillary transverse narrowness with 
bilateral posterior crossbite 
No previous history of nasal disease 
 
RME (bonded) Nasal cavity 
 
Görgülü et al. 2011 
(61) 
Turkey Prospective cohort 
study 
15 Pts 
(9 boys, 6 girls) 
mean age 13.86y +/- 
1.4yrs 
(range 12-16y) 
No Maxillary constriction, Bilateral 
posterior crossbite, Requiring rapid 
maxillary expansion treatment, Clinical 
crown length able to provide sufficient 
anchorage for the RME appliance 
RME (bonded) Nasal cavity 
Haralambidis et al. 
2009 (63) 
Turkey Prospective cohort 
study 
24 Pts 
(10 boys, 14 girls) 
Mean age 14.5yrs  
Class I =10, Class II 
=14 
 (CVM: cervical 
vertebrae maturation; 
CVM3:9 Pts, 
CVM4:9 Pts, 
CVM5:6 Pts) 
No No specified 
 
RME (bonded) Anterior nasal cavity 
Kabalan et al. 2015 
(53) 
Canada Randomised 
controlled trial 
61 Pts 
11-17 years  
20 (random 
allocation from total 
sample) 
Diagnosed need for maxillary 
expansion due to skeletal transverse 
deficiency 
RME (tooth-
borne) 
RME (bone-
Nasal Cavity 
 
 
 
 
Full permanent dentition erupted. borne) 
Li et al. 2015 (70) China Prospective cohort 
study  
35 Pts 
(18 boys,17 girls) 
mean age 12.1±1.1yrs 
 
No Narrow maxilla 
Unilateral or bilateral crossbite 
Growth potential (cervical vertebrae 
maturation index) 
Clear and complete CBCT records 
No cleft lip and/or palate 
No facial damage 
No issues with trauma, adenoids or 
other factors affecting craniofacial 
development 
RME (Hyrax) Nasopharynx 
Oropharynx 
Marini et al. 2007 (66) Italy Prospective cohort 
study 
30 Pts 
(14 boys, 16 girls) 
mean age 7.5yrs 
range 7-8yrs 
No Posterior crossbite, due to narrow 
maxilla 
RME (bonded) Palatal 
Oliveira De Felippe et 
al. 2008 (64) 
USA Prospective cohort 
study 
38 Pts 
(19 boys, 19 girls) 
mean age 13yrs 
(boys:8-16yrs,  
girls:9-15yrs) 
No Growing patients who were to receive 
rapid maxillary expansion treatment. 
No history of upper respiratory 
diseases or anomalies 
RME (Haas) 
RME (banded) 
RME (bonded) 
Nasal cavity 
Palatal 
Palaisa et al. 2007 
(65) 
USA Prospective cohort 
study 
19 Pts (sexes not 
given) 
aged 8-15yrs (detailed 
age stats not given) 
 
 
 
No Require banded or bonded hyrax 
palatal expander as part of their 
comprehensive orthodontic treatment. 
Require at least 4mm of maxillary 
expansion. No previous orthodontic 
treatment or craniofacial growth 
anomalies 
 
RME (banded 
or bonded)  
Nasal cavity 
Pangrazio-Kulbersh et 
al. 2012 (58) 
USA Prospective cohort 
study 
Banded RME: 13 Pts 
(7 boys, 6 girls) 
mean age 12.6 +/- 
1.8yrs 
 
Bonded RME: 10 Pts 
(5 boys, 5 girls) 
mean age 13.5 +/- 
2.1yrs 
 
No Constricted maxillary arch (with or 
without cross-bites,) 
Full permanent dentition 
RME (banded) 
RME (bonded) 
Maxillary sinuses  
Posterior Airway 
Ribeiro 2011 (71); Brazil Prospective cohort 15 mixed dentition Pts No Transverse maxillary deficiency RME (bonded) Nasopharynx  
 
 
 
 
Ribeiro et al. 2012 (57) study (7 boys, 8 girls) 
mean age 7.5yrs 
(no range or SD given) 
 
Unilateral posterior crossbite 
 
Oropharynx  
Smith et al. 2012 (56) USA/ 
Egypt 
Retrospective cohort 
study 
20 Pts 
(8 boys, 12 girls) 
mean age 12.37yrs 
range 8-15yrs 
(SD 1.9months) 
 
No Pts with bilateral maxillary constriction, 
No previous orthodontic/orthopaedic 
treatment. 
No systemic diseases, craniofacial 
anomalies or TMJ disorders. No 
tonsillectomy or adenoidectomy. No 
carious, gingival or periodontal lesions. 
No metallic restorations. RME planned 
as part of comprehensive orthodontic 
treatment 
 
RME (banded) Nasal cavity  
Maxillary sinuses 
Nasopharynx  
Oropharynx  
Hypopharynx  
 
Sökücü et al. 2010 
(62) 
Turkey Prospective 
controlled clinical trial 
15 Pts 
(7 boys, 8 girls) 
Mean age 12.41 +/- 
0.98yrs 
 
15 Pts 
(8 boys, 7 girls) 
Mean age = 12.46 
+/- 0.56yrs 
Ideal untreated 
occlusions 
RME group had posterior cross-bites 
 
 
RME (bonded) 
 
 
 
Nasal cavity 
 Zeng & Gao 2013 
(54) 
China Prospective cohort 
study 
16 Pts 
(10 boys, 6 girls) 
mean age 12.73 +/- 
1.73yrs (range 10-15) 
No Constricted Maxilla (with or w/o 
posterior cross-bite) 
Upper first molars & first premolars 
erupted 
RME (banded) Lower Nasal cavity 
Nasopharyngeal 
Oropharyngeal 
yr, year; RME, rapid maxillary expander; SD, standard deviation; Pt, patient; CVM, cervical vertebral maturation. 
 
 
 
 
Supplementary Table 9. Measurement Techniques, Time-points, Airway Regions & Key Result Summary of Included Studies. 
Study 
Measurement 
Technique 
Follow-up Points 
Region Volume 
Measured 
Treated Group Recorded Changes 
Approx % 
Change
*
 
Outcome 
Almuzian et al 2016 
(67) 
CBCT T1- Prior to RME 
T2- After complete 
expansion 
Left maxillary sinus 
Right maxillary sinus 
Lower nasal cavity 
Upper nasopharynx 
Upper retropalatal 
Lower retropalatal 
T2-T1: 6855±3728 vs 6940±4207 mm
3 
T2-T1: 7133±3348 vs 6855 ±3681 mm
3 
T2-T1: 5600±3374 vs 4785 ±2195 mm
3 
T2-T1: 3101±1374 vs 2736 ±1395 mm
3 
T2-T1: 492±731 vs 527 ±827 mm
3 
T2-T1: 2994±2226 vs 3305 ±2265 mm
3
 
-1.2% 
3.8% 
17% 
13.4% 
-6.6% 
-9.4% 
Not-effective (P=0.82) 
Not-effective (P=0.5) 
Not-effective (P=0.06) 
Effective (P=0.04) 
Effective (P=0.04) 
Not-effective (P=0.27) 
Azaredo 2014 (68) CBCT T1- Prior to RME 
T2- After complete 
expansion 
Total upper airway vol T1-T2: 7451.6±3490.7 vs 8120±3764.7 mm
3
 n/a Not-effective (P=0.109) 
Babacan et al. 2006 
(15) 
AR (ND & D) T1- Prior to RME 
T2- n/a 
T3- After 6m retention 
Nasal cavity vol T1-T3 (ND): 0.16 ± 0.02 vs 0.18 ± 0.02 cc 
T1-T3 (D): 0.18 ± 0.02 vs 0.21 ± 0.02 cc 
12.5% 
17% 
Effective (P<0.05) 
Effective (P <0.05) 
Cappellette et al. 
2008 (17) 
AR 
(D) 
T1- Prior to RME 
T2- After complete 
expansion 
T3- n/a 
Right nasal cavity vol 1 
Right nasal cavity vol 2 
Left nasal cavity vol 1 
Left nasal cavity vol 2 
T1-T2: n/a 
T1-T2: n/a 
T1-T2: n/a 
T1-T2: n/a 
n/a 
n/a 
n/a 
n/a 
Effective (P=0.002) 
Effective (P=0.023) 
Effective (P=0.004) 
Not-effective (P=0.189) 
Chang 2011 (69); 
Chang et al. 2013 
(55) 
CBCT T1- Prior to RME 
T2- n/a 
T3- After 3-4m retention 
Retropalatal vol 
Retroglossal vol 
Total upper airway vol 
T1-T3: 1201.2 ± 3018.82 mm
3
 
T1-T3: 533.8 ± 3486.82 mm
3
 
T1-T3: 1735.1 ± 5970.95mm
3
 
19% 
10.9% 
15.5% 
Not-effective (P=0.1604) 
Not-effective (P=0.5765) 
Not-effective (P=0.2967) 
Cordasco et al. 
2012 (60) 
CT T1- Prior to RME 
T2- n/a 
T3- After 7m 
Anterior Nasal cavity vol 
Posterior Nasal cavity vol 
Total Nasal cavity vol  
T1-T3: 0.58 ± 0.33 cm
3
 
T1-T3: 0.69 ± 0.34 cm
3
 
T1-T3: 1.27 ± 0.65 cm
3
 
7% 
8.8% 
8% 
Effective (P<0.05) 
Effective (P <0.05) 
Effective (P <0.05) 
Darsey et al. 2012 
(59) 
CBCT T1- Prior to RME 
T2- After complete 
expansion 
T3- n/a 
Right Mx sinus vol 
Left Mx sinus vol 
Total Mx sinus vol 
T1- T2: 12460.8 ± 3891.5 vs 12582.8 ± 3856.2 mm
3
 
T1- T2: 12953.4 ± 4939.8 vs 12900.7 ± 4270.2 mm
3
 
T1- T2: 25414.2 ± 8447.8 vs 25483.5 ± 7490.9 
0.9% 
-0.4% 
0.3% 
Not-effective (P=0.763) 
Not-effective (P=0.923) 
Not-effective (P=0.929) 
Doruk et al. 2007 
(16) 
CT 
AR (ND & D) 
T1- Prior to RME 
T2- n/a 
T3- After 6m retention 
 
 
Nasal cavity vol (CT) 
Nasal cavity vol (AR) 
T1-T3: 38.9 ± 7.14 vs 43.9 ± 8.26 cm
3
 
T1-T3 (D): 38.5 ± 7.46 vs 46.5 ± 9.48 cm
3
 
13% 
21% 
Effective (P<0.05) 
Effective (P <0.05) 
Görgülü et al. 2011 
(61) 
CT T1- Prior to RME 
T2- n/a 
T3- After 6m retention 
Nasal cavity vol T1-T3: 1419.47±647.69mm
3
 12.1% Effective (P <0.001) 
 
Haralambidis et al. 
2009 (63) 
CT T1- Prior to RME 
T2- n/a 
Anterior nasal cavity vol T1-T3: 5437.36±1097.13mm
3
 vs 
6045.7±1247.31mm
3
 
11.2% Effective (P=0.0001) 
 
 
 
 
T3- After 3m retention 
Kabalan et al. 2015 
(53) 
AR(ND & D) T1- Prior to RME 
T2- n/a 
T3- After 6m retention 
Right nasal cavity vol 1 
Right nasal cavity vol 2 
Left nasal cavity vol 1 
Left nasal cavity vol 2 
T1-T3: -0.15 ± 1.64 cm
3
 
T1-T3: 1.1 ± 4.53 cm
3
 
T1-T3: 0.19 ± 1.69 cm
3
 
T1-T3: -0.26 ± 1.77 cm
3
 
n/a 
n/a 
n/a 
n/a 
Not-effective (P>0.05) 
Not-effective (P >0.05) 
Not-effective (P >0.05) 
Not-effective (P>0.05) 
Li et al.2015 (70) CBCT T1- Prior to RME 
T2- 16 days after complete 
RME expansion 
T3- After 4m retention 
Nasopharyngeal volume 
 
Oropharyngeal volume 
 
T1:3462±1147 mm
3 
vs T2:4496±983 mm
3 
T1:3462±1147 mm
3 
vs T3:4437±896 mm
3 
 
T1:7236±2398 mm
3 
vs T2:7515±2362 mm
3 
T1:7236±2398 mm
3 
vs T3:7612±2078 mm
3
 
29.9% 
28.2% 
n/a 
n/a 
Effective (P<0.05) 
Effective (P<0.05) 
Not-effective (P n/a) 
Not-effective (P n/a) 
Marini et al. 2007 
(66) 
Photogrammetry T1- Prior to RME 
T2- n/a 
T3- After 3m retention 
 
Palatal vol T1-T3: n/a 2.3-8.5% Effective (P<0.001) 
Oliveira De Felippe 
et al. 2008 (64) 
AR (ND) 
Model scanning 
T1- Prior to RME 
T2- After complete 
expansion 
T3- After 4m retention 
Nasal cavity vol R 
Nasal cavity vol L 
Nasal cavity vol Total 
 
 
Palatal vol 
 
 
T1-T2: 7.58±2.72cm
3
 vs 9.25±2.89 cm
3
 
T2-T3: 9.25±2.89 vs 9.19±2.39 cm
3
 
T1-T3: 7.58±2.72cm
3
 vs 9.19±2.39 cm
3 
T1-T3: 5100.01±1324.91mm
3 
vs 6414.79±3167.49 
mm
3
 
 
 
18% 
17.5% 
40.6% 
25.8% 
 
 
Effective (P=0.007) 
Not-Effective (P=0.265) 
Effective (P=0.000) 
Effective (P=0.000) 
Palaisa et al. 2007 
(65) 
CT T1- Prior to RME 
T2- After complete 
expansion 
T3- After 3m retention 
Nasal cavity vol T1-T2: 2.08±2.66 cm
3
  
T2-T3: 4.90±2.30 cm
3
 
T1-T3: 6.99±2.45 cm
3
 
10.7% 
22.6% 
35% 
Effective (P <0.05) 
Effective (P <0.05) 
Effective (P <0.05) 
Pangrazio-Kulbersh 
et al. 2012 (58) 
CBCT T1- Prior to RME 
T2- n/a 
T3- After 6m retention 
Maxillary sinus vol 
Banded 
Bonded 
 
 
 
Posterior Airway vol 
Banded 
Bonded 
 
T1-T3: 21769.38 ± 6275.28 vs 24352.32 ± 6664.68 
mm
3
 
T1-T3: 27674.75 ± 10404.67 vs 29412.09 ± 9782.13 
mm
3
 
 
T1-T3: 11858.93 ± 3988.74 vs 19277.53 ± 17421.86 
mm
3
 
T1-T3: 11518.73 ± 4742.75 vs 11423.56 ± 2544.65 
mm
3
 
 
11.8% 
6.3% 
 
63% 
-1% 
Effective 
 Banded (P <0.01) 
 Bonded (P <0.01) 
Not-effective 
 Banded (P=0.16) 
 Bonded (P=0.93) 
Ribeiro 2011 (71); 
Ribeiro et al. 2012 
(57) 
CBCT T1- Prior to RME 
T2- n/a 
T3- After 4m retention 
Nasopharynx 
Oropharynx 
T1-T3: 879.77±2628.01mm
3
 
T1-T3: 239.36±532.99mm
3
 
11.5% 
16.2% 
Not-effective (P=0.11) 
Effective (P=0.05) 
Smith et al. 2012 
(56) 
Spiral CT T1- Prior to RME 
T2- n/a 
Nasal cavity vol 
Nasopharynx vol 
T1-T3: 3641±5545mm
3
 
T1-T3: 522±548mm
3
 
15.2% 
16.2% 
Effective (P=0.00) 
Effective (P=0.00) 
 
 
 
 
T3- After 3m retention Oropharynx vol 
Hypopharynx vol 
Right Mx sinus vol 
Left Mx sinus vol 
 
T1-T3: 184±4335mm
3
 
T1-T3: 170±1021mm
3
 
T1-T3: 326±1898mm
3
 
T1-T3: 452±1825mm
3
 
-1.7% 
5.1% 
2.6% 
3.7% 
Not-effective (P=0.11) 
Not-effective (P=0.22) 
Not-effective (P=0.50) 
Not-effective (P=0.17) 
Sökücü et al. 2010 
(62) 
AR (ND & D) T1- Prior to RME 
T2- After complete 
expansion 
T3- After 6m retention 
Nasal cavity volume T1-T2 (ND): 0.172±0.042cm
3
 vs 0.220±0.044 cm
3
 
T1-T2 (D): 0.198±0.048cm
3
 vs 0.266±0.047 cm
3
 
T2-T3 (ND): 0.220±0.044cm
3 
vs 0.205±0.043 cm
3
 
T2-T3 (D): 0.266±0.047cm
3
 vs 0.242±0.041 cm
3
 
T1-T3 (ND): 0.172±0.042cm
3
 vs 0.205±0.043 cm
3
 
T1-T3 (D): 0.198±0.048cm
3 
vs 0.242±0.041 cm
3
 
28% 
34.3% 
-6.8% 
-9% 
19.1% 
22.2% 
Effective (P <0.05) 
Effective (P <0.05) 
Effective (P <0.05) 
Effective (P <0.05) 
Effective (<P 0.05) 
Effective (P <0.05) 
 Zeng & Gao 2013 
(54) 
CBCT T1- Prior to RME 
T2- n/a 
T3- After 3m retention 
Lower Nasal vol 
Nasopharyngeal vol 
Oropharyngeal vol 
T1-T3: 1348.5±640.1mm
3
 
T1-T3: -178.7±884.7mm
3
 
T1-T3: -1325.0±2232.7mm
3
 
8.2% 
-6.8% 
-12.2 
Effective (P=0.000) 
Not-effective (P=0.447) 
Effective (P=0.037) 
*Calculated % value based on published data; 
RME, rapid maxillary expansion; AR, acoustic rhinometry; ND, non decongested; D, decongested; CT, computed tomography; CBCT, cone beam computed tomography; Mx, maxillary; vol, 
volume; T1, time point prior to RME; T2, time point immediately after RME; T3, time point after retention; n/a, not available. 
 
 
 
 
Supplementary Table 10. Expansion and Retention Protocols of Included Studies. 
Study Expander Design Expansion Protocol Expansion Period Retention 
Almuzian et al. 2016 (67) Hyrax cast type 
(fully covered buccal buccal 
teeth form 1
st
 molars to 
canines with occlusal holes to 
aid removal) 
¼ turn (0.25mm) twice a day until 
overexpansion (palatal cusps of upper 
molars occluded with the buccal 
cusps of the lower molars) 
Mean active expansion 14 days 
(range:12-21 days) 
Not specified 
Azaredo 2014 (68) Hass or Hyrax 
(details not specified) 
1mm (4 turns) immediately after 
appliance cementation followed by 
0.5mm (2 turns) per day 
Active expansion of 19 days 
(total expansion of 8mm) 
Appliance left in place for 3 months after 
active expansion (doesn‟t state if it was 
fixed or not) 
Babacan et al. 2006 (15) Hyrax full coverage bonded ¼ turn per day until desired 
expansion achieved 
Mean activation period 25.2 ± 3.82 
days “until the desired suture opening 
was achieved” 
Screw tied off with 0.014” ligature wire, 
Hyrax removed after 1 week to minimize 
discomfort. 
Cleaned and used as removal retainer for 
approximately 6 month retention period. 
Mean retention period 6.15 ± 0.17 
months 
Cappellette et al. 2008 (17) Hyrax banded on U6s 6-8 turns on first day, then 2 turns per 
day thereafter until the complete 
maxillary expansion 
 
Not stated, activated “until the 
complete maxillary expansion” 
Appliance left in place for 3 months after 
active expansion (doesn‟t state if it was 
fixed or not) 
Chang 2011 (69); Chang et 
al. 2013 (55) 
Hyrax banded on U4s & U6s One activation (90° turn) of jackscrew 
per day 
Clinical observation of 2-3mm of 
overexpansion marked the 
termination of expansion 
28 consecutive days or until 
resolution of the posterior crossbite. 
Hyrax left in place and tied off with a 
ligature wire as well as composite 
material 
 
Cordasco et al. 2012 (60) Hyrax banded to U6s only Screw initially turned 8 times (1.6mm 
initial activation), then patients 
instructed to turn 3 times per day 
(0.6mm activation per day) until end-
point 
Expansion continued until mild over-
correction of 2mm was achieved. 
Average active expansion period of 
12.6 days 
Hyrax locked with composite & removed 
7months after it was inserted 
(approximately 6.5 months retention 
period) 
Darsey et al. 2012 (59) Hyrax banded either U6s only 
with arms, or U4s & U6s 
2 turns per day 
 
Expansion time: 3-4 weeks 
Mean expansion time: 22.3 days 
Until maxillary arch constriction was 
overcorrected 
(overcorrection amount not specified) 
 
 
Doruk et al. 2007 (16) Hyrax full coverage bonded Activate the screw (1/4 turn) twice a 
day for first week (0.5mm), then once 
Mean active expansion:20.7 +/- 4.6 
days 
Retention protocol not described  
Mean retention period = 6 +/- 2.2 months 
 
 
 
 
per day thereafter (0.25mm) Until the posterior crossbite was 
eliminated 
 
Görgülü et al. 2011 (61) Hyrax bonded, acrylic occlusal 
coverage of 3mm from U4-U7  
2 turns per day (approximately 
0.25mm per turn) until end-point 
including standardized amount of 
overcorrection (not-specified)  
 
 
Not specified  
“Amount of expansion was 
approximately 8mm at appliance 
screw” 
Not specified 
Haralambidis et al. 2009 
(63) 
Hyrax bonded acrylic cap splint Hyrax activated twice by clinician at 
cementation, parent then activates 
screw 1/4 turn twice daily until end 
point. 
 
Duration: 23.7± 5.5 days 
Expansion terminated just before 
reaching Bu cross-bite in all patients 
Appliance screw secured with stainless 
steel ligature wire and left in place for 3 
months, then soldered TPA with palatal 
arms extending along premolars. 
Follow-up records taken at appliance 
removal and then TPA placed right away 
 
Kabalan et al. 2015 (53) Hyrax banded on U4s & U6s Activate expander 2 turns daily 
(0.5mm/day) until appropriate 
expansion 
 
Not specified  Hyrax fixed with ligature wire, RME left in 
place for 6 months 
Li et al.2015 (70) Hyrax Activate expander 2 turns daily 
(0.5mm/day)  
Active expansion of 16 days 
 
Hyrax screw secured with composite and 
appliance left in place for 3months after 
end of active expansion 
 
Marini et al. 2007 (66) Hyrax bonded splint expander ¼” turn (0.25mm) twice a day  Until maxillary molar palatal cusps 
contacted lower molar buccal cusps 
RME left in place for 3months after end of 
activation 
 
Oliveira De Felippe et al. 
2008 (64) 
Haas-banded hyrax - U4s & 
U6s with palatal acrylic pads 
Banded hyrax - U4s & U6s 
Bonded hyrax with occlusal 
capping splint 
2 per day (50%) 
1 per day (42%) 
1 every other day (8%) 
Midline diastema formation was 
observed in 32 of 38 patients 
Average active expansion: 40days 
(range: 14-173days). 
Clinical observation of 2-3mm of 
overexpansion 
When occlusal aspect of lingual cusp 
of maxillary first molar contacted the 
occlusal aspect of the facial cusp of 
mandibular first molars. 
RME was fixed (not specified) and left in 
place for retention 
Average retention period:121days 
(range :94-183 days) 
 
Palaisa et al. 2007 (65) Hyrax bonded or banded Not specified Average activation of hyrax:6.1mm +/- 
1.7mm 
Not specified 
Pangrazio-Kulbersh et al. 
2012 (58) 
Hyrax Banded to U6s with 
palatal wire, or  
Not specified  
(calculated to be approximately 1 turn 
Active expansion 4-6 weeks  
Activation amount 6-10mm 
6 months retention 
details not provided 
 
 
 
 
Bonded acrylic cap coverage per day) 
Ribeiro 2011 (71); Ribeiro 
et al. 2012 (57) 
Hyrax bonded Not specified Not specified 4 months retention period 
details not provided 
Smith et al. 2012 (56) Hyrax banded either U4s & 
U6s,  
or UDs & U6s 
Turn appliance 2 times twice daily 
(total 0.8mm activation per day) until 
end-point 
 
Until palatal cusps of maxillary first 
permanent molars contacted the 
buccal cusps of the mandibular first 
molars 
 
Exact method not described, assuming 
expander left in place for 3months 
Average period from last activation to 
final records 91 +/- 3.5days 
Sökücü et al. 2010 (62) Hyrax acrylic bonded full tooth 
& tissue borne 
¼ turn twice per day When occlusal aspect of U6 lingual 
cusp contacted the occlusal aspect of 
the L6 facial cusp 
Mean activation period 22.4 +/- 
4.01days 
 
Expansion screw fixed with 0.014” 
stainless steel ligature wire. Appliance 
left passive for 1 week to minimize 
discomfort at removal. Appliance 
removed, cleaned and used as a 
removable retention appliance. 
Mean retention period 6.2 +/- 0.16 
months 
 Zeng & Gao 2013 (54) Hyrax banded on U4s & U6s Activated expander 2 turns per day 
until end-point 
 
Activation period ranged 2-3weeks 
(2.7-6.3mm). 
When palatal cusp of U6s contacted 
Buccal cusps of L6s 
Hyrax screw locked with composite and 
left in place for further 3m 
     
U4s, upper first premolars; U6s, upper first molars; L6s, lower first molars; TPA, transpalatal arch. 
 
 
 
 
 
Supplementary Table 11. Details on the composition of the main outcome (composite airway volume) 
Study Volumes included in composite airway volume 
Almuzian et al. 2016 (67) Left sinus/right sinus/lower nasal cavity/nasopharynx/upper velopharynx/lower velopharynx 
Azeredo 2014 (68) Oropharynx 
Chang 2011 (69); Chang et al. 
2013 (55) 
Velopharynx/oropharynx 
Cordasco et al. 2012 (60) Total nasal cavity 
Darsey et al. 2012 (59) Total sinus 
Doruk et al. 2007 (16) Total nasal cavity 
Gorgulu et al. 2011 (61) Total nasal cavity 
Haralambidis et al. 2009 (63) Total nasal cavity 
Li et al. 2015 (70) Nasopharynx/oropharynx 
Palaisa et al. 2007 (65) Total nasal cavity 
Pangrazio-Kulbersh et al. 2012 
(58) 
Total sinus/nasopharynx/velopharynx/oropharynx 
Ribeiro 2011 (71); Ribeiro et 
al. 2012 (57) 
Nasopharynx/oropharynx 
Smith et al. 2012 (56) Left sinus/right sinus/total nasal cavity/nasopharynx/hypopharynx/oropharynx 
Zeng & Gao 2013 (54) Total nasal cavity/nasopharynx/oropharynx 
 
 
 
 
 
 
Supplementary Table 12. Results of the effect of rapid maxillary expansion on each separate volume (mm
3
) originally reported in the treated groups of included studies. 
Outcome Measurement Timing Studies Change (95% CI) P 95% Predictive Interval I
2
 (95% interval) 
Left S CT post-expansion 2 -75.51 (-19369.28,19218.25) 0.994 NA 0% (NA) 
Left S CT post-retention 1 452.00 (-15544.54,16448.54) 0.956 NA NA 
Right S CT post-expansion 2 214.29 (-16458.42,16886.99) 0.980 NA 0% (NA) 
Right S CT post-retention 1 326.00 (-16310.39,16962.39) 0.969 NA NA 
TS CT post-expansion 1 69.30 (-61183.71,61322.31) 0.998 NA NA 
TS CT post-retention 1 2215.29 (-119.91,4550.49) 0.063 NA NA 
Lower NC CT post-expansion 1 815.00 (-17422.27,19052.27) 0.930 NA NA 
Anterior NC CT post-retention 1 580.00 (-1249.39,2409.39) 0.534 NA NA 
Posterior NC CT post-retention 1 690.00 (-1194.84,2574.84) 0.473 NA NA 
Left NC CT post-expansion 1 1238.00 (-11132.68,13608.68) 0.844 NA NA 
Left NC CT post-retention 1 3671.00 (-8084.55,15426.55) 0.541 NA NA 
Left NC AR-basal post-expansion 1 445.45 (-191.58,1082.48) 0.171 NA NA 
Left NC AR-basal post-retention 1 751.32 (153.51,1349.13) 0.014 NA NA 
Left NC AR-basal post-retention (long-term) 1 1442.11 (844.30,2039.92) 0.000 NA NA 
Right NC CT post-expansion 1 838.00 (-10789.41,12465.41) 0.888 NA NA 
Right NC CT post-retention 1 3320.00 (-9076.30,15716.30) 0.600 NA NA 
Right NC AR-basal post-expansion 1 1001.96 (382.32,1621.60) 0.002 NA NA 
Right NC AR-basal post-retention 1 860.79 (279.70,1441.88) 0.004 NA NA 
Right NC AR-basal post-retention (long-term) 1 1632.37 (1051.28,2213.46) <0.001 NA NA 
TNC CT post-expansion 1 2080.00 (-20645.13,24805.13) 0.858 NA NA 
TNC CT post-retention 7 1362.46 (-1755.02,3739.41) 0.261 -1755.02,4479.94 0% (0%,58%) 
TNC AR-basal post-expansion 2 642.53 (-693.82,1978.87) 0.346 NA 86% (NA) 
TNC AR-basal post-retention 4 53.62 (-79.43, 186.67) 0.430 -438.02,545.25 73% (0%,88%) 
TNC AR-basal post-retention (long-term) 1 3075.26 (2136.36,4014.16) <0.001 - NA 
TNC AR-decongested post-expansion 1 69.00 (46.58,91.42) <0.001 - NA 
TNC AR-decongested post-retention 3 25.31 (3.69,46.92) 0.022 -114.82,165.44 0% (0%,73%) 
PV CT post-retention 1 1314.78 (382.21,2247.35) 0.006 NA NA 
PV CT post-retention (long-term) 1 1414.48 (481.91,2347.05) 0.003 NA NA 
 
 
 
 
upper VP CT post-retention 1 -35.00 (-4545.15,4475.15) 0.988 NA NA 
lower VP CT post-expansion 1 -311.00 (-13145.69,12523.69) 0.962 NA NA 
VP CT post-retention 1 1201.20 (-20937.36,23339.76) 0.915 NA NA 
NP CT post-expansion 2 662.27 (-6443.84,7768.38) 0.855 NA 0% (NA) 
NP CT post-retention 4 396.71 (-3234.57,4028.00) 0.830 -7574.94,8368.36 0% (0%,68%) 
OP CT post-expansion 2 390.43 (4.58,776.27) 0.047 NA 0% (NA) 
OP CT post-retention 4 70.72 (-399.76,541.20) 0.768 -1269.58,1411.03 53% (0%,81%) 
HP CT post-retention 1 170.00 (-8779.29,9119.29) 0.970 NA NA 
NP+VP+OP CT post-retention 1 4151.74 (-620.01,8923.49) 0.088 NA NA 
VP+OP CT post-retention 1 1735.10 (-42052.95,45523.14) 0.938 NA NA 
CI, confidence interval; S, sinus; CT, computed tomography; NA, not applicable; TS, total (left+right) sinus; NC, nasal cavity; AR, acoustic rhinometry; TNC, total nasal cavity; PV, palatal vault; 
VP, velopharynx; NP, nasopharynx; OP, oropharynx; HP, hypopharynx. 
 
 
 
 
 
Supplementary Table 13. Results of additional analyses performed, including subgroup analyses, meta-regressions and assessment of reporting bias with the Egger test. 
 
 
Composite airway volume; CT; post-retention Total nasal cavity volume; CT; post-retention 
Factor SG Studies Change (95% CI) P among SG Studies Change (95% CI) P among SG 
Appliance design Banded 6 1299.04 (484.23,2113.85) 0.726 3 1305.18 (-1616.49,4226.84) 0.986 
  Bonded 5 1040.57 (433.15,1647.99)   3 1255.89 (-2912.13,5423.92)   
                
    Studies Coefficient (95% CI) P Studies Coefficient (95% CI) P 
Patient age   9 -53.54 (-387.05,279.98) 0.716 5 -16.55 (-2005.84,1972.74) 0.981 
Male/female ratio   10 -408.10 (-2329.76,1513.55) 0.637 6 157.90 (-6842.81,7158.60) 0.953 
                
Egger's test for 
reporting bias 
   11 0.77 (-0.83,2.36) 0.304 - - - 
        
    Studies Change (95% CI) P 
 
Difference between SGs (95% CI) P among SGs 
Sensitivity analysis Prospective 9 1032.53 (518.72, 1546.50) <0.001  -560.86 (-2139.51, 1017.79) 0.442 
 Retrospective 2 2710.49 (-791.69, 6212.66) 0.129    
CT, computed tomography; SG, subgroup; CI, confidence interval. 
  
 
